Optibiotix Health Share Discussion Threads

[belgrano2] 18/6/2018 08:43

im on the shakes as well now, really good.. will lose Lbs and make £;s.
can recommend new formula.

[belgrano2] 18/6/2018 08:40

another excellent rns today, really looking up for this company.. highly encouraging news.

[rogerbridge] 18/6/2018 08:39

Another promising agreement. In the SIPP as a slow burner but with great expectations.

[shrewdmole] 18/6/2018 08:35

John

2 things are possible why the rise is limited.
1. Has the ii finished? We've talked a lot on here about ii not getting the positions they wanted in the placing and hence the recent return to around placing price and some substantial buys.

2. I've mentioned it privately but there are many looking for revenue targets which obviously soh won't and can't give.

However I do wonder if the Rns contained a projected launch date (closest quarter) whether that would appease a few doubters. It sounds like Morley are way down the line so won't be the same delay to market at some of the others.

On top of that a bar chart showing approximate launches for each company would IMHO look very very appetising.

Eg Morley just signed but could be as little as 4-8 weeks for products on sale.
Galenicum I think it is that signed ages ago but launch h2.

Put all the deals in a spread sheet with approx quarterly launches and it would give a better picture without soh having to hang himself on revenue numbers.

S

[monkeywench1] 18/6/2018 08:32

Yes we suddenly have massive fcf lol.

[rafboy] 18/6/2018 08:29

Yes, we should be higher this morning.

[2350220] 18/6/2018 08:25

How many companies in your portfolios sign 50/50 agreements?
Of all the shares in my own SIPP & ISA NO other company has managed this feat apart from Opti.
AND Opti has done this several times into the bargain.
It still beggars belief that we only get a 1p rise, if that.
John

[runthejoules] 18/6/2018 08:16

Bought £5k for me old mum this morning! Holding till she dies, hopefully over 2 years away! Good luck all, jam this evening now!

[aspex] 18/6/2018 07:16

If the bigger players are still asleep it is moves like Morleys that will cause them to think.All IMVHO.

[someuwin] 18/6/2018 07:06

RNS Number : 6301R

OptiBiotix Health PLC

18 June 2018

OptiBiotix Health plc

("OptiBiotix" or the "Company")

Manufacturing, supply and profit sharing agreement with Morley Foods

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol,diabetes and skin care, announces it has entered into a manufacturing and supply agreement with John Morley Foods, ("Morleys"). The agreement grants Morleys an exclusive licence to manufacture and supply the SlimBiome(R) weight management technology in muesli packs within the UK, in return for 50% of the profit.

Morleys is a private company and a leading supplier of high quality ingredients to breakfast cereal and food manufacturers including major retailers and many global consumer food brands. Morleys have invested substantive resource over the last six months in developing a range of muesli products containing SlimBiome(R) to be sold as own label products to major retailer or as product line extensions to existing well- known brands.

SlimBiome(R), a patented combination of natural ingredients developed by experts to provide hunger free weight loss, recently won the award for Weight Management of the Year at Vitafoods European trade show. Morleys will use their best endeavours to promote and expand the supply of SlimBiome(R) in muesli packs, bringing it to the attention of major retailers and branded cereal manufactures within the United Kingdom. The development of muesli breakfast products allows OptiBiotix to extend its GoFigure(TM) range of online products and create 'health and wellbeing' own label brands for supermarkets within the UK.

This agreement, with one of the UK's leading ingredient suppliers, is another step in expanding the range of products containing SlimBiome(R) to meet the needs of major UK retailers and the Iarge consumer markets of India and the USA.

Stephen O'Hara, CEO of OptiBiotix, commented: "We are pleased to announce the signing of a manufacturing, supply and profit sharing agreement with Morleys. We chose Morleys due to their reputation as one of the UK's leading suppliers of specialist ingredients and the energy and passion they have shown in developing a wide range of muesli products containing SlimBiome(R) over the last six months. We believe working with Morleys, and similar partners around the world, provides the best opportunity of meeting the requirements of major retailers and global brands who are looking to develop healthy products to meet growing consumer demand."

Simon Brown, Managing Director of John Morley Group added: "This is an exciting development, and a range like this has not been done by anyone else. Mueslis are healthy, but now we're creating a muesli-plus, something that will help people control mid-morning snacking urges by making them feel fuller for longer. Not only that but SlimBiome(R), as a prebiotic, is good for healthy gut bacteria. Our plan is to launch single serving muesli pots as well as the standard bagged format to target the individual market. We are delighted to be working with OptiBiotix and taking our relationship forward in new and exciting ways."

[elrico] 17/6/2018 23:45

IMHO Akums has the potential to open up huge global markets, including the USA. With 600 companies, such as Abbott, Novartis, P&G, Sanofi and Sandoz and a global footprint we run the risk on under estimating the strategic move AKUMs offers OPTI.

Global Presence

With manufacturing expertise along with innovation & quality approach, Akums has its presence marked in the Indian & global pharmaceutical space with its export subsidiary UNOSOURCE PHARMA LTD. We export our formulations to various global markets. We have filed substantial numbers of dossiers in different countries. Around 1500 dossiers have been filed as per CTD, ACTD and guidelines of the MOH of various countries.

There are plans in pipeline to create joint ventures in various countries, to set up manufacturing units and/or packaging units for semi-finished products exported from Akums, India.

The manufacturing units have International approvals like; ANVISA – Brazil, FDA Philippines, NAFDAC Nigeria, FDB – Ghana, PMPB – Malawi, PPB – Kenya, NDA-Uganda, MOH – Libya, MOH – Cambodia, DDA – Nepal, CD&DA – Sri Lanka, MOH – Vietnam, MOH-Afghanistan, MOH-Yemen, DPM – Ivory Coast, TFDA Tanzania, ZAZIBONA, MOH – Kazakhstan.

We have our global foot prints in countries like; Ukraine, Vietnam, Cambodia, Kenya, Ivory Coast, Venezuela, Nepal, Nigeria, Ghana, Sri Lanka, Uganda, Ethiopia, Tajikistan, Philippines, Malawi, Malaysia, Bhutan, Brazil, Honduras, Hong Kong, Yemen, Libya, Afghanistan, Belarus, Myanmar, Liberia, Burundi, Mozambique, Rwanda, Zambia, Georgia, Kazakhstan, Kyrgyzstan, Turkmenistan, Uzbekistan, Bolivia, Peru, Nicaragua, Chile, Uruguay, Guatemala, Costa Rica and Francophone Countries.

[parob] 17/6/2018 23:42

As I have already mentioned to Elrico, once TERN's share price hits 70p I will top slice a few and you all know where it's going.

[parob] 17/6/2018 23:38

I reckon we will find out during the next 4 weeks.

[parob] 17/6/2018 23:36

Yes Akums but I'm talking major US pharma tie up:"following on from the deal with Akums (as announced on 16 May 2018) the Company has received partner interest to license LP(LDL) (R) as a pharmaceutical product in the USA and a number of other international markets."That would set the price alight.

[paulhoodwinked] 17/6/2018 23:31

Don't OPTI already have one confirmed pharma tieup with several other possibilities?

[parob] 17/6/2018 23:11

I am heavily into tern - thankfully bought the bulk between 3.22p-10.5p - but just missed out on a 60p entry price in VRS in the last pullback. OPTI will be the next disruptive stock to blow imv and I'm hoping it will be on the back of Pharma tie up news. As I have mentioned in the opti twitter group:"I have a feeling pharma news is close and that will break us out of the descending channel."Almost 1 month since the last placing.UOM Skinbiotix news came 6 weeks after the Feb 2016 placing when SOH said:Stephen O'Hara, CEO of OptiBiotix, said: "We are delighted that Seneca, as a major shareholder and respected wealth manager, have increased their stake in OptiBiotix. The funds will be used to further accelerate our development programmes to capitalise on the growing number of opportunities arising in the rapidly evolving microbiome space and build shareholder value."Recent placement RNS:"growing commercial interest in the Company's award winning technology and products have generated new opportunities which if capitalised on have the potential for significant value enhancement. These include:- -- The development of the Company's cholesterol and blood pressure reducing strain LP(LDL) (R) as a pharmaceutical product. Under existing plans OptiBiotix's products have been developed for the ingredient and supplements market. Following on from the deal with Akums (as announced on 16 May 2018) the Company has received partner interest to license LP(LDL) (R) as a pharmaceutical product in the USA and a number of other international markets. Whilst partners will fund regulatory submissions and clinical studies, there is a requirement for OptiBiotix to invest in developing process controls and quality procedures to comply with pharmaceutical production of LP(LDL) (R) .

[2350220] 17/6/2018 23:06

Great video. Thanks Elrico.
Onwards and upwards. . .
With no stop loss!
John

[parob] 17/6/2018 22:42

They are both disruptive stocks.

[parob] 17/6/2018 22:05

Look what happened to both TERN and VRS when they broke out of their descending channels.

[monkeywench1] 17/6/2018 21:26

Sales profit cash flow are key.

[parob] 17/6/2018 19:37

Breaking out of the descending channel is key.

[monkeywench1] 17/6/2018 19:35

Gotta love a dreamer.

[loungeact] 17/6/2018 19:23

£10+ by end of August. :)

[monkeywench1] 17/6/2018 18:47

Start the ball rolling! This has been ramped endlessly for 2 years ( share price was 75p then ) and look what that has achieved. Stop the ramping.

The market will price the company on profits/cashflow not jam tomorrow and ramping.